Growing chronic diseases driving demand for antibody-based diagnostics. Expanding drug discovery increasing reagent utilization in research. Advancements in antibody validation improving research accuracy and efficiency. High production costs and qua... Explore Report »
Biotechnology
Research Reports in Biotechnology
Showing 10 results in Biotechnology
Targeted protein degradation is a technique that involves the use of bifunctional or induced-proximity molecules to recruit a disease protein into an E3 ubiquitin ligase or lysosome for degradation by the natural cellular degradation pathways. This t... Explore Report »
Growing ethical concerns and legislative changes surrounding animal testing are a key driver. This technology provides a more accurate and human-relevant platform for assessing drug efficacy and toxicity, moving away from animal models that often fai... Explore Report »
The rising number of clinical trials for gene and cell therapies drives the U.S. plasmid DNA manufacturing market growth. These advanced treatments are heavily dependent on a large and consistent supply of high-quality plasmid DNA to support their de... Explore Report »
Increasing global cancer burden is driving demand for cell line development by accelerating the need for stable and high-yield cell lines to support biologics and monoclonal antibody production. The rising global RD expenditures is fueling market gro... Explore Report »
Rise in infectious and chronic diseases is driving the use of molecular biology enzymes, reagents and kits to support molecular diagnostics, early disease detection and genetic analysis in clinical settings. Expanding biopharmaceutical RD and drug di... Explore Report »
There is a growing need for more accurate methods to test drugs before they are given to people. This technology helps by providing a better way to model human diseases and how the body will respond to new treatments, which can reduce the high rate o... Explore Report »
Rising focus on preventative healthcare continues increasing consumer adoption of genetic screening solutions. AI-powered genomics analytics platforms continue improving genomic interpretation capabilities. Data privacy and ethical concerns remain a ... Explore Report »
The rising prevalence of chronic and infectious diseases is driving demand for early and accurate molecular diagnostic testing globally. Advancements in genomics and automation are enabling faster, high-throughput molecular testing in clinical and re... Explore Report »
Increasing need for personalized medicine fuels market growth. Supports targeted treatment, early detection, and use in oncology and genetic disorders. Improvements in NGS technologies boost adoption. Faster, accurate, and cost-effective sequencing i... Explore Report »
